Cantor Fitzgerald Lowers Price Target On Canopy Growth Stock Post Q3 Earnings
Canopy Growth Corporation (NASDAQ: CGC) (TSX: WEED) recently unveiled financial
Why Mobilicom Shares Are Trading Higher Today
Mobilicom Ltd. (NASDAQ: MOB) shares are trading higher after the company announced it has entered into a strategic partnership with a prime contractor for the U.S. Department of Defense (DOD).
A Cannabis Company Sued By Its Former CEO Sets The Record Straight After False Claims Circulate
Bright Green Corporation (NASDAQ: BGXX) is clapping back at statements made by its former CEO, John Fikany.
S&P 500 Down 2%; Mobilicom Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 2% on Tuesday.
The Dow traded down 2.06% to 33,129.04 while the NASDAQ fell 2.39% to 11,506.10. The S&P 500 also fell, dropping, 2.05% to 3,995.66.
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.
EXCLUSIVE: House Of Kush Hitting It Out Of The Park For Athletes And The Rest Of Us With Pure Legacy Strains
The House of Kush, a majority Black-owned business, is rooted in science and based on legacy strains by preserving both the history and integrity of the past for the future.
Tesla Signs New EV Component Deal: Here’s The Company Involved, Why It’s Important
Electric vehicle leader Tesla Inc (NASDAQ: TSLA) has dominated its subsector of the automotive market.
D-Wave Quantum’s AI/ML Commercialization Strategy Wins Analyst Conviction; Expects Continued Momentum
Benchmark analyst David Williams maintained a Buy on D-Wave Quantum Inc (NYSE:QBTS) with a $4 price target. Continuing to expand on its…
Aileron Therapeutics Shelves Development On Chemoprotection Agent, Shares Fall
Aileron Therapeutics (NASDAQ:ALRN) announced that a review of initial data from its Phase 1b chemoprotection trial of ALRN-6924 in p53-mutated breast…
Corvus Pharma’s HIV Candidate Shows Potential To Prevent Virus Re-Emergence
Corvus Pharmaceuticals Inc (NASDAQ:CRVS) announced new data demonstrating the potential of CPI-818, an ITK inhibitor, to reduce the need for chronic…